Sr Director, Head of Global Medical Scientific Communications Excellence & Innovation

Biogen•Cambridge, MA

15d•$245,000 - $337,000

About The Position

About This Role This enterprise-level role sets the strategic direction for global scientific communications and ensures Biogen delivers consistent, credible, and innovative scientific exchange across all channels. The Senior Director, Head of Scientific Communications Excellence & Innovation is a strategic partner within Global Medical Affairs, responsible for building and leading Biogen’s worldwide scientific communications capability. This role ensures consistent, compliant, and impactful scientific communications across publications, congresses, and emerging digital/omnichannel platforms to support high-quality scientific exchange across the Medical organization. Through the strategic development and implementation of cross-functionally accepted global frameworks, governance, and ways of working, this role enables Medical teams to shape and deliver a coherent scientific narrative across geographies and the asset lifecycle. As the enterprise owner for scientific communications excellence and innovation, the role drives standardization, digital transformation, and continuous improvement across the organization. What You’ll Do Enterprise Scientific Communications Frameworks & Governance: Serve as the enterprise owner for scientific communications excellence, establishing global frameworks, standards, and governance models that ensure consistency, quality, and compliance across publications, congresses, and emerging scientific communication channels. Define and maintain cross-functional, cross-TA operating models, clarifying decision rights, escalation pathways, and ways of working to improve efficiency and reduce duplication. Develop and sustain transparent governance structures to communicate scientific communications policies, standards, prioritization principles, and updates across Global and Regional teams. Align with Global Medical TA leads and partner with Global Therapeutic Area Publication and Communication Leads to enable consistent application of enterprise guardrails, while preserving TA-specific scientific strategy ownership within Global TA teams. Publications Capability & Community of Practice Leadership: Lead the Global Publications Community of Practice (CoP) as the single accountable community for publication excellence across Biogen. Establish, evolve, and communicate enterprise publication standards, including SOP interpretation, templates, tools, systems, and operational best practices spanning the end‑to-end publication lifecycle. Enable TA Publication Leads by providing clear, consistent guardrails and shared infrastructure that support high‑quality, compliant, and efficient publication planning and execution. Set the strategic direction and oversee continuous improvement initiatives across publication operations, including process simplification, system optimization, and vendor governance. Global Congress Excellence & Prioritization: Lead and oversee the evolution of Biogen’s Worldwide Medical congress excellence framework, positioning congresses as a critical scientific communication channel within the broader scientific communications ecosystem. Design, maintain, and govern a transparent global congress prioritization framework, including defined criteria to guide selection, tiering, and resourcing decisions across all therapeutic areas and geographies. Establish global standards for congress planning, execution, governance, and post‑congress insight capture, enabling comparability and learning across therapeutic areas and driving continuous improvement initiatives. Digital, Omnichannel & Innovation Enablement: Advance enterprise‑wide digital and omnichannel scientific communication capabilities by identifying, piloting, and scaling new formats and platforms that enhance access, engagement, and scientific impact. Champion responsible adoption of AI‑enabled tools and automation to improve efficiency, quality, and scalability across scientific communications workflows, in partnership with IT and compliance stakeholders. Monitor external trends and emerging technologies to future‑proof scientific communications operating models. Measurement, Insights & Continuous Improvement: Define and standardize enterprise approaches to medical imperatives and impact measurement, focusing on insights‑to‑action evaluation across scientific communication channels. Develop metrics to assess reach, engagement, and insights‑to‑action across channels. Use performance data, stakeholder feedback, and post‑execution reviews to continuously evolve enterprise frameworks and elevate scientific communications excellence.

Requirements

Advanced degree in life sciences, medicine, pharmacy, communications, or related field (PhD, MD, PharmD, MA/MS/MBA).
15+ years of experience in Medical Affairs, Scientific Communications, and/or Publications within pharma/biotech.
Proven experience leading enterprise or global capabilities, governance models, or communities of practice in matrixed organizations.
Deep understanding of publication standards, scientific communications channels, and evolving digital/AI enabled approaches.
Strong cross-functional leadership, stakeholder influence, and change management capabilities functional leadership, stakeholder influence, and change management capabilities.

Responsibilities

Serve as the enterprise owner for scientific communications excellence, establishing global frameworks, standards, and governance models that ensure consistency, quality, and compliance across publications, congresses, and emerging scientific communication channels.
Define and maintain cross-functional, cross-TA operating models, clarifying decision rights, escalation pathways, and ways of working to improve efficiency and reduce duplication.
Develop and sustain transparent governance structures to communicate scientific communications policies, standards, prioritization principles, and updates across Global and Regional teams.
Align with Global Medical TA leads and partner with Global Therapeutic Area Publication and Communication Leads to enable consistent application of enterprise guardrails, while preserving TA-specific scientific strategy ownership within Global TA teams.
Lead the Global Publications Community of Practice (CoP) as the single accountable community for publication excellence across Biogen.
Establish, evolve, and communicate enterprise publication standards, including SOP interpretation, templates, tools, systems, and operational best practices spanning the end‑to-end publication lifecycle.
Enable TA Publication Leads by providing clear, consistent guardrails and shared infrastructure that support high‑quality, compliant, and efficient publication planning and execution.
Set the strategic direction and oversee continuous improvement initiatives across publication operations, including process simplification, system optimization, and vendor governance.
Lead and oversee the evolution of Biogen’s Worldwide Medical congress excellence framework, positioning congresses as a critical scientific communication channel within the broader scientific communications ecosystem.
Design, maintain, and govern a transparent global congress prioritization framework, including defined criteria to guide selection, tiering, and resourcing decisions across all therapeutic areas and geographies.
Establish global standards for congress planning, execution, governance, and post‑congress insight capture, enabling comparability and learning across therapeutic areas and driving continuous improvement initiatives.
Advance enterprise‑wide digital and omnichannel scientific communication capabilities by identifying, piloting, and scaling new formats and platforms that enhance access, engagement, and scientific impact.
Champion responsible adoption of AI‑enabled tools and automation to improve efficiency, quality, and scalability across scientific communications workflows, in partnership with IT and compliance stakeholders.
Monitor external trends and emerging technologies to future‑proof scientific communications operating models.
Define and standardize enterprise approaches to medical imperatives and impact measurement, focusing on insights‑to‑action evaluation across scientific communication channels.
Develop metrics to assess reach, engagement, and insights‑to‑action across channels.
Use performance data, stakeholder feedback, and post‑execution reviews to continuously evolve enterprise frameworks and elevate scientific communications excellence.

Benefits

Medical, Dental, Vision, & Life insurances
Fitness & Wellness programs including a fitness reimbursement
Short- and Long-Term Disability insurance
A minimum of 15 days of paid vacation and an additional end-of-year shutdown time off (Dec 26-Dec 31)
Up to 12 company paid holidays + 3 paid days off for Personal Significance
80 hours of sick time per calendar year
Paid Maternity and Parental Leave benefit
401(k) program participation with company matched contributions
Employee stock purchase plan
Tuition reimbursement of up to $10,000 per calendar year
Employee Resource Groups participation